Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Feb 2026 for SENSORION, €5.3M. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Redmile Biopharma Investments III: trading record in brief
This profile gathers the share dealings of Redmile Biopharma Investments III in Sensorion. Between 8 August 2023 and 30 January 2026, the trades on record add up to 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 3 February 2026: a transaction of €5.3M, in Sensorion. The median gap between a trade and its publication by AMF is 4 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Companies and markets linked to Redmile Biopharma Investments III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
18,928,571 shares@ €0.2817.9% of flowActionEuronext Growth ParisISIN FR00125964682026DD1092507
2,781,914 shares@ €0.635.9% of flowActionEuronext Growth ParisISIN FR00125964682024DD960541
16,842,105 shares@ €0.5732.4% of flowActionEuronext Growth ParisISIN FR00125964682024DD951162
46,428,571 shares@ €0.2843.8% of flowActionEuronext Growth ParisISIN FR00125964682023DD923832
4 of 4 declarations
